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Abstract.  Calcifying cartilages  show a restricted  ex- 
pression of tissue transglutaminase.  Immunostaining  of 
newborn rat paw bones reveals expression only in the 
epiphyseal growth plate.  Tissue transglutaminase  ap- 
pears  first intracellularly  in the proliferation/matura- 
tion zone and remains  until  calcification of the tissue 
in the lower hypertrophic  zone.  Externalization  occurs 
before mineralization.  Subsequently,  the enzyme is 
present  in the interterritorial  matrix  during provisional 
calcification  and in the calcified cartilage  cores of 
bone trabeculae.  In trachea,  mineralization  occurring 
with maturation  in the center of the cartilage  is ac- 
companied by expression of tissue transglutaminase  at 
the border of the hydroxyapatite deposits. 
Transglutaminase  activity also shows a  restricted 
distribution  in cartilage,  similar to the one observed 
for tissue transglutaminase  protein.  Analysis of tissue 
homogenates  showed that the enzyme is present  in 
growth plate cartilage,  but not in articular  cartilage, 
and recognizes a  limited set of substrate proteins.  Os- 
teonectin is coexpressed with tissue transglutaminase 
both in the growth plate and in calcifying tracheal  car- 
tilage and is a  specific substrate for tissue trans- 
glutaminase  in vitro. 
Tissue transglutaminase  expression in skeletal tis- 
sues is strictly regulated,  correlates  with chondrocyte 
differentiation,  precedes cartilage calcification,  and 
could lead to cross-linking  of the mineralizing  matrix. 
T 
RANSGLUTAMINASE (EC 2.3.2.13) is an enzyme that 
catalyzes  a  Ca2§  acyl-transfer  reaction  in 
which new v-arnide bonds are formed between 3/-car- 
boxamide groups of peptide-bound glutamine residues and 
various primary amines (for review see Lorand and Conrad, 
1984; Greenberg et al.,  1991).  A glutamine residue serves 
as acyl-donor and the most common acyl-acceptors are pri- 
mary amino groups of some naturally occurring polyamines, 
like putrescine or spermidine, or e-amino groups of peptide- 
bound lysine residues. In the latter case, the reaction results 
in the formation of ~/-glutamyl-r  cross-links in or be- 
tween  proteins.  The  number  of glutaminyl  substrates  is 
highly  restricted,  while the tolerance  to  structural  differ- 
ences in acyl-acceptors is considerable. 
Transglutaminases  form a large protein family (Ichinose 
et al.,  1990) and have a wide distribution amongst tissues 
and body fluids. Thus, proteins modified by transglutamin- 
ases are found throughout the organism, e.g., in fibrin clots 
in hemostasis and wound healing, in cell membranes of ter- 
minally  differentiated  erythrocytes,  in  extracellular  ma- 
trices, and in the cornified envelope of the epidermis (for re- 
view see Greenberg et al.,  1991).  In some of these tissues, 
a  role for transglutaminases  in the apoptotic program has 
been postulated as enzymes of this class are accumulated in 
the  cytoplasm of cells undergoing  terminal  differentiation 
both in vivo and in vitro (for review see F6sus et al.,  1991). 
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The  abundant  tissue  transglutaminase  is  a  monomeric 
globular  protein  with  an Mr of ,077,000  (Ichinose  et al., 
1990; Greenberg et al.,  1991).  It is often highly expressed 
at sites of pathologic injury where it acts together with factor 
XIIIa, the plasma transglutaminase  (Weinberg et al.,  1991; 
Wiebe  et  al.,  1991).  Several  extracellular  proteins  like 
fibrin(ogen) (Achyuthan et al.,  1988; Shainoff et al.,  1991), 
fibronectin  (F6sus et al.,  1986),  vitronectin  (Sane  et al., 
1988; Skorstengaard et al., 1990), nidogen/entactin (Aesch- 
limann and Paulsson,  1991; Aeschlimann et al.,  1992), col- 
lagen type III N-propeptide (Bowness et al.,  1987) and os- 
teopontin  (Prince  et  al.,  1991)  have  been  identified  as 
specific glutaminyl  substrates  for tissue transglutaminase. 
Together  with  the  observed  association  of  tissue  trans- 
glutaminase  expression  with  programmed  cell  death  and 
pathologic injury, the cross-linking  of extracellular  matrix 
components indicates a physiological function of the enzyme 
in maintaining  the integrity of the tissue by fixation of the 
matrix at the site of the lesion (Upchurch et al.,  1991). 
During  endochondral  bone formation,  the chondrocytes 
pass through a series of differentiation stages in which they 
undergo proliferation, a high rate of matrix synthesis, hyper- 
trophy  and calcification  of the hypertrophied  chondrocyte 
matrix (Hunziker and Schenk, 1989, and references therein). 
They are eventually removed from cartilage through tissue 
resorption, vascularization and bone remodeling. The calci- 
fied cartilage matrix  serves as a substrate for initial osteo- 
genesis. 
Cartilage contains collagen type II, a fiber forming colla- 
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tide of type II collagen, termed chondrocalcin,  is enriched 
in the epiphyseal growth plate and may play a role in cartilage 
calcification (Hinek et al.,  1987). Several quantitatively mi- 
nor collagens have been detected in cartilage. One of these, 
type X collagen, was shown to be exclusively expressed by 
hypertrophic chondrocytes in tissues undergoing endochon- 
dral bone formation (Schmid and Linsenmayer,  1985). Os- 
teonectin is one of the most abundant noncollagenous pro- 
teins in bone (Termine et al.,  1981a; Bolander et al.,  1988), 
but may also be expressed in cartilage (Nomura et al.,  1988; 
Metsiiranta et al.,  1989). It contains multiple calcium bind- 
ing domains,  one in the form of an EF-hand near the car- 
boxyl terminus (Engel et al., 1987; Maurer et al., 1992), and 
might thus be involved in the mineralization  process.  The 
protein is also widely distributed in other tissues, although 
in lower amounts (Mason et al., 1986; Dziadek et al., 1986). 
The  present  study  addresses  the  distribution  of tissue 
transglutaminase  in skeletal tissues and the role of the en- 
zyme in physiological cross-linking of the extracellular ma- 
trix. We show a correlation between the expression of tissue 
transglutaminase protein and transglutaminase activity with 
subsequent calcification of cartilage,  and identify abundant 
proteins of cartilage and bone matrix,  i.e., collagen type II 
and osteonectin as glutaminyl  substrates for the enzyme. 
Materials and Methods 
Protein Reagents 
Tissue transglutaminase was purified from guinea pig liver (Connellan et 
al.,  1971) and osteonectin prepared from rat long bone by a modification 
of the method of Fisher et al. (1987). Native recombinant  human BM-40/os- 
teonectin (Nischt et al.,  1991) was kindly provided by Dr. R. Timpl,  Max- 
Planck-Institute  for Biochemistry (Germany).  Reduction and alkylation of 
guanidine-HC1/EDTA denatured recombinant  BM-40/osteonectin  was done 
as described (Aeschlimann et al.,  1992).  Human plasma fibronectin was 
a  kind gift of Dr.  K.  Ingham,  American Red  Cross.  BSA  and N,N- 
dimethylcasein was from Serva (Heidelberg,  Germany). 
Histochemical Methods 
Antisera to guinea pig tissue transglutaminase (Aeschlimann and Paulsson, 
1991),  rat  osteonectin,  and  dansylated  (hapten)  Lz'mulus polyphemus 
bemocyanin (carrier; Sigma Chemical Co., St. Louis,  MO) were raised in 
rabbits and affinity  purified when needed  (Aeschlimann and Paulsson, 
1991). Cycloheptaamylose  .dansyl-chloride  complex  was prepared (Kino- 
shita et al.,  1974) and proteins dansylated  by addition of 20 mg complex 
per 10 mg protein in 1 ml of 0.1 M sodium phosphate buffer, pH 7.7. The 
mixture was stirred for 90 min in the dark and low molecular weight com- 
pounds removed by passage  over a PD 10 column (Pharmacia, Uppsala, 
Sweden).  The specificity of the antibodies was demonstrated in immuno- 
blots of crude extracts  of the tissue of origin. 
Tissues were prepared for paraffin embedding by fixation in 4% (wt/vol) 
paraformaldehyde  in PBS (8 mM sodium phosphate, pH 7.4, 0.15 M sodium 
chloride) at 4~  overnight and complete demineralization in 0.42 M EDTA, 
0.5%  (wt/vol)  paraformaldehyde.  For cryopreservation,  tissues were em- 
bedded in Tissue-Tek  a (Miles, Inc., Naperville,  IL) and frozen on dry ice. 
For  immunohistochemistry,  sections  (5  /zm) were  cut,  mounted on 
gelatine-coated  slides and dried. Paraffin-embedded sections were prepared 
for  immunolabeling  by  deparaffinization  and  rehydration  in  50  mM 
Tris/HC1, pH 7.4, 0.15 M NaC1 (TBS). Cryosections  were used unfixed or 
after post-fixation (the expression,  "post-fixation" is used to describe fixa- 
tion of tissue sections that had been adsorbed onto slides and dried) in 4% 
(wt/vol)  paraformaldehyde,  acetone or  methanol.  To  increase antibody 
penetration, sections were digested for 1 h with 40 mU/ml chondroitinase 
ABC (Sigma Chemical Co.) in TBS containing 0.01% (wt/vol) BSA where 
indicated.  Endogenous peroxidase  was blocked by incubation in methanol 
containing 1% (vol/vol) H202 and nonspecific  antibody binding by treat- 
ment with 1% (wt/vol) BSA in TBS. Sections were treated with specific anti- 
bodies,  nonimmune ChromPure  rabbit IgG  (Jackson  ImmunoResearch 
Labs, West Grove,  PA) or preimmune rabbit serum for 1 h, followed by 
peroxidase-conjugated  swine anti-rabbit IgG (Dakopatts,  Glostrup, Den- 
mark) for 45 min. Antibodies were diluted in 1% BSA/TBS. The slides were 
developed  with 3-amino-9-ethylcarbazole  (Sigma  Chemical Co.)  /H202 
and counterstained with Mayers H~nalaun (Merck, Darmstadt, Germany). 
For detection of transglutaminase activity, unfixed BSA-treated cr),~osec- 
tions were incubated for 1 h in 0.1 M Tris/HC1, pH 8.3, 5 mM CaC12, 12 
/zM monodansylcadaverine,  with or without addition of 10.8 tzg/mi of exoge- 
nous tissue transglutaminase (250/.d/section).  Inhibition was done by addi- 
tion of EDTA to 25 mM. Protein-bound label was detected with anti-dansyl 
antiserum as described above. Hydroxyapatite  was shown by yon Kossa's 
stain for calcium phosphate. 
Radioactive Transglutaminase  Assay 
Transglutaminase-catalyzed  incorporation of [1,4-3H]putrescine (24.8 Ci/ 
mmol, Amersham Corp., Amersham, UK) into putative substrate proteins 
was done for 30 rain at 37~  as described previously  (Aeschiimann and 
Paulsson,  1991). 
Detection of Transglutaminase Activity in 
Cartilage Homogenates 
Articular and epiphyseal growth zone (Hinek et al., 1987) cartilage was iso- 
lated from calf tibia] and femoral bones. Cartilage (0.25 g wet tissue/rnl) 
was briefly  homogenized  in 0.1  M  Tris/HC1,  pH 8.3, containing 0.3  M 
NaC1, 50 mM CaC12, 5 mM dithiothreitol, the protease inhibitors phenyl- 
methanesulfonyl fluoride (1 raM), benzamidine HC1 (10 raM) and 6-amino- 
hexanoic  acid (0.1 M) and the transglntaminase substrate (amine donor) 
monodansylcadaverine  (1 raM, Serva).  To one half of each homogenate 1 
nag exogenous tissue transglutaminase/g wet tissue was added and incuba- 
tion was done at 37~  for 3 h. Homogenates incubated either in the presence 
or absence of exogenous tissue transglntaminase  were centrifuged at 5,000 g 
for 15 rain, the pellets washed with reaction buffer by repeated suspending 
and centrifugation,  and the supernatants pooled to yield a total of 5 ml/g 
tissue of buffered salt extract.  Pellets were extracted in a total of 5 ml/g tis- 
sue each of 4 M guanidine HCI/50 mM Tris/HCl, pH 6.0, containing pro- 
tease inldbitors (see above), N-ethylmaleinimide  (1 raM) and EDTA (0.1 M), 
first while shaking at room temperature for 75 min and then by washing as 
above. Insoluble material was washed in 0.5 M acetic acid and digested with 
porcine pepsin (Serva,  17 mAnson U/rag; 2 mg/g tissue wet weight) in a 
total of 3 rrd/g tissue of 0.5 M acetic acid at 4~  for 14 h to solubilize type 
II collagen  (Miller,  1971). 
SDS-PAGE and Immunoblotting 
SDS-PAGE (Laemmli,  1970) was done in 4-20% gradient gels.  Proteins 
Figure 1. Expression of tissue transglutaminase and osteonectin in developing long bones of 4-d old rat. Serial sections (5 #m) of fixed, 
decalcified and paraffin-embedded tissue,  showing a tarsal bone (A and B) or the distal growth plate of tibia (C),  were incubated with 
antibodies to tissue transglutaminase (A and C) or osteonectin (B), developed with peroxidase-conjugated secondary antibodies (3-amino- 
9-ethylcarbazole/H202 used  as  peroxidase  substrate solution:  brown  stain),  and counterstained with Mayers  Hiimalaun (blue stain). 
(Negative controls for immunochemical results are not shown but were submitted to the journal and available to the referees.) In B, the 
section was digested with chondroitinase ABC before incubation with the antibody. The differentiation stages of the chondrocytes were 
assigned according to the cellular morphology and are indicated on the left and below: proliferation zone (PZ), upper hypertrophic zone 
(including the maturation zone) (U/-/Z), lower hypertrophic zone (LHZ) with the zone of provisional calcification (PC-Z; cartilage calcifica- 
tion was assessed by von Kossa staining on cryosections of the same tissue),  and the metaphysis (MP). Bars,  50 #m. 
The Journal of Cell Biology, Volume 120, 1993  1462 Aeschlimann et aL  Tissue Transglutaminase  Expression  in Skeletal  Tissues  1463 Figure 2. Tissue transglutaminase  antigen in the growth plate matrix is revealed by chondroitinase ABC digestion. Unfixed cryosections 
(5 ~tm) showing the distal growth plate of tibia of a 4-d old rat were stained with antibodies to tissue transglutaminase  without (A) or 
with (B) prior treatment with chondroitinase ABC. (Negative controls for immunochemical results are not shown but were submitted to 
the journal  and available to the referees.) The arrows indicate the border between the lower hypertrophic  zone of the growth plate and 
the metaphysis. Bar, 50 #m. 
reduced with 2-mercaptoethanol (1%,  vol/vol) were detected by staining 
with Coomassie brilliant blue R or after transfer onto nitrocellulose (Towbin 
et al., 1979).  Binding of  primary antibody was visualized using peroxidase- 
conjugated swine anti-rabbit IgG (Dakopatts) and 4-chloro-l-naphthol  as the 
chromogenic agent. 
Results 
Expression  of Tissue Transglutaminase  and 
Osteonectin in Long Bones 
The distribution of tissue transglutaminase was studied in the 
tarsal and metatarsal bones as well as in the distal portion 
of the tibia from 1-4-d old rats. Affinity purified antibodies 
were used in combination with immunoperoxidase staining. 
Tissue transglutaminase was found to be preferentially ex- 
pressed in the growth plate. An acceptable preservation of 
the  cellular morphology and retention  of the  intracellular 
material was obtained in fixed, paraffin-embedded sections. 
Tissue transglutaminase  is detected mainly intracellularly, 
and appears first in the proliferation/maturation zone of the 
growth plate (Fig.  1 A). Subsequently, the enzyme is selec- 
tively accumulated in the cytoplasm of the cells during the 
maturation  steps.  Intracellular  expression  of the  enzyme 
ceases in the lower layers of hypertrophic chondrocytes be- 
fore calcification of the  tissue  (Fig.  1  C).  When  sections 
were digested with chondroitinase ABC to remove chondroi- 
tin/dermatan sulfate chains from the matrix, the staining pat- 
tern was similar to that without enzyme treatment. (Negative 
controls for immunohistochemical results are not shown but 
were submitted to the journal and available to the referees.) 
Some cells in the resting cartilage became positive, but much 
more weakly so than those in the growth plate. Thus, tissue 
transglutaminase might be expressed also by resting chon- 
drocytes, but if so at low levels. 
The disappearance of intracellular tissue transglutaminase 
before calcification, led us to try to demonstrate an extracel- 
lular pool by use of frozen sections. In such sections, much 
intracellular material is lost, but a better accessibility and/ 
or  antigenicity  of  the  extracellular  matrix  structures  is 
achieved. The remaining cellular immunoreactivity for tis- 
sue transglutaminase was restricted to the collapsed growth 
plate chondrocytes (Fig.  2 A).  Upon treatment with chon- 
droitinase ABC, tissue transglutaminase was revealed in the 
interterritorial  cartilage  matrix  of  growth  plate  and  the 
calcified cartilage cores of trabeculae (Fig. 2 B). The expres- 
sion  appears  as  a  gradient  in  the  hypertrophic  zone  and 
reaches  maximal  intensity  in  the  zone  of  provisional 
calcification. The enzyme is externalized and incorporated 
into the extracellular matrix. It persists in the calcified carti- 
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incorporation  of  3.  Tissue transglutaminase catalyzed 
[3H]putrescine into osteonectin and collagen type II. The incorpo- 
ration of [3H]putrescine into rat bone osteonectin/BM-40 (1), hu- 
man recombinant osteonectin/BM-40  (2), bovine articular collagen 
type II (pepsin fragment) (3) was compared to the incorporation 
into the reference proteins bovine milk N,N-dimethylcasein (4; 
contains one amine incorporation site), human plasma fibronectin 
(5; contains several amine incorporation sites) and BSA (6; does 
not contain any amine incorporation sites) as previously described 
(Aeschlimann and Paulsson, 1991). All values are the average of 
three to six independent measurements. The bars indicate the stan- 
dard deviation from mean values. 
lage cores of trabeculae until it is removed by bone remodel- 
ing (Fig. 2 B). Tissue transglutaminase was detectable nei- 
ther in mineralized matrix of cortical or trabecular bone nor 
in  newly  deposited  osteoid  along  the  trabecular  surface 
(Figs.  1 A, 2, A and B). "Post-fixation" of the tissue before 
chondroitinase  ABC  digestion  abolished  the  unmasking 
effect, explaining the absence of extracellular immunoreac- 
tivity in paraffin sections. 
Osteonectin  is  predominantly  present  in  cortical  and 
trabecular  bone  matrix,  but  is  similarly to  tissue  trans- 
glutaminase also expressed by growth plate chondrocytes 
(Fig. 1 B). Osteonectin is seen first in the maturation/upper 
hypertrophic zone. It appears slightly later in the chondro- 
cyte differentiation program than tissue transglutaminase. 
Native Osteonectin is a Transglutaminase Substrate 
The coexpression of tissue transglutaminase and osteonectin 
in the growth plate led us to investigate whether osteonectin 
is a transglutaminase substrate. This was done by incubation 
of purified tissue transglutaminase with either osteonectin 
(also known as BM-40  [Dziadek et al.,  1986] or SPARC 
[Mason et al., 1986]) purified from rat bone (Fig. 3, bar/) 
or with the recombinant human protein (Fig. 3, bar 2) in the 
presence  of  [3H]putrescine  and  Ca  2+  (Aeschlimann  and 
Paulsson, 1991). Isolation of osteonectin from rat bone had 
been done by decalcification with EDTA in the presence of 
the denaturing agent guanidine HC1, and this protein prepa- 
ration was inactive in the assay.  Human recombinant os- 
teonectin/BM-40  had  been  purified  avoiding  denaturing 
steps, and incorporated the radioactive amine. Treatment of 
native  recombinant osteonectin  with  guanidine  HC1  and 
EDTA led to 89-95 % loss in [3H]putrescine  incorporation 
and reduction and alkylation of the denatured recombinant 
protein completely abolished incorporation. Thus, osteonec- 
tin/BM-40 has to be in the native conformation to act as a 
glutaminyl substrate for tissue transglutaminase. The fact 
that osteonectin is a substrate supports the notion that the en- 
zyme may act in the growth plate by cross-linking matrix 
proteins. 
Distribution of Transglutaminase Activity in 
Long Bones 
Transglutaminase activity was detected on unfixed cryosec- 
tions of the distal growth plate of the tibia by incubation with 
the substrate monodansylcadaverine and with Ca  2+ either in 
presence or absence of exogenous enzyme (Aeschlimann and 
Paulsson,  1991). Monodansylcadaverine that had been in- 
corporated into protein was subsequently detected by anti- 
bodies raised against the dansyl group. The distribution of 
enzyme activity in cartilage corroborated the previous local- 
ization of tissue transglutaminase protein. In the absence of 
exogenous enzyme, the activity was found only in chondro- 
cytes and matrix of the growth plate (Fig. 4 A). The activity 
gradually increases  with successive steps  of chondrocyte 
differentiation, but could not be detected in the calcified car- 
tilage  cores  of bone  trabeculae,  indicating  that  the  im- 
munoreactive enzyme present in this compartment (Fig. 2 B) 
is inactive due to entrapment in hydroxyapatite. Transgluta- 
minase activity was also detected in newly deposited osteoid. 
This  result,  together  with  the  demonstration  that  tissue 
transglutaminase antigen is absent from mineralized bone 
matrix and osteoid (Fig.  2  B),  indicates that osteoblasts 
and/or bone marrow cells express a  transglutaminase im- 
munochemically distinct from the tissue type enzyme. Incu- 
bation of sections with exogenous tissue transglutaminase 
gave a homogenous strong staining, showing that glutaminyl 
substrates are present throughout the cartilage (Fig. 4 B). 
This demonstrates that the confined distribution of endoge- 
nous transglutaminase activity is indeed due to a restricted 
expression of the enzyme and not of the glutaminyl substrate 
proteins.  Because  transglutaminase  activity  is  strongly 
Ca2+-dependent,  the  specificity of the  assay  was  demon- 
strated by inhibition with EDTA. (Negative controls for im- 
munohistochemical results are not shown but were submitted 
to the journal and available  to the referees.) 
Transglutaminase Activity and Substrate 
Proteins in Homogenates of  Epiphyseal Growth Plate 
and Articular Cartilage 
Homogenates of bovine epiphyseal growth plate and of bo- 
vine articular cartilage were incubated in Ca2+-containing 
buffer  with  the  transglutaminase  substrate  monodansyl- 
cadaverine. Incubation was done either in the absence or 
presence of exogenous tissue transglutaminase to detect both 
intrinsic enzyme activity and substrate proteins that can be 
labeled by excess exogenous enzyme.  After labeling,  the 
homogenates were sequentially extracted with a buffered salt 
solution (extract I) and a guanidine HCI/EDTA solution (ex- 
tract II). The residue was digested with pepsin to solubilize 
the triple helical domains of cartilage collagens, mainly type 
II collagen (extract III). Analysis by SDS-PAGE followed by 
Aeschlimann  et al.  Tissue Transglutaminase Expression in Skeletal Tissues  1465 Figure 4. Detection of transglutaminase activity present in sections of  the distal growth plate of the tibia of 4-d old rat. Unfixed  cryosections 
(5/zm) were incubated with monodansylcadaverine  alone (A) or monodansylcadaverine  together with purified tissue transglutaminase (B) 
in  Ca2§  buffer. Protein-bound  monodansylcadaverine was  subsequently detected  by  use  of anti-dansyl  antiserum  and 
peroxidase-conjugated secondary antibodies. (Negative controls for immunochemical results are not shown but were submitted to the jour- 
nal and available to the referees.) Bar, 50/zm. 
Coomassie-staining (Fig. 5 A) or immunoblotting with anti- 
dansyl antiserum (Fig. 5, B-D) revealed that many proteins 
of different Mr  are  able to  incorporate the labeled amine 
when treated with exogenous tissue transglutaminase,  both 
in the epiphyseal growth zone and articular cartilage (Fig. 5, 
C and D). The band patterns obtained from the two tissues 
were comparable, indicating that a similar set of proteins act 
as glutaminyl substrates for tissue transglutaminase in both 
tissues. Collagen type II was heavily labeled and appears to 
be a glutaminyl substrate in the cartilage matrix (Fig. 5,  C 
and D; extract III). Similarly, in vitro incubation of collagen 
type  II  and  tissue  transglutaminase  in  the  presence  of 
[3H]putrescine and Ca  2§ led to an incorporation of the ra- 
dioactive amine into collagen type II (Fig. 3, bar 3). Tissue 
transglutaminase is itself  able to act as a glutaminyl substrate 
(Birckbichler et al., 1977; Aeschlimann and Paulsson, 1991) 
and is therefore also labeled in the cartilage extracts where 
exogenous enzyme had been added (Fig. 5, C and D; extract 
I, II). 
Labeled proteins were detected in the extract from growth 
plate cartilage also without the addition of exogenous tissue 
transglutaminase (Fig. 5 B), but not in the extract from artic- 
ular cartilage (results not shown). Endogenous enzyme is ei- 
ther absent from articular cartilage or present in quantities 
not detectable with this  assay.  It cannot be excluded that 
some of the endogenous transglutaminase activity observed 
in the growth plate homogenate may be due to a contamina- 
tion of blood plasma derived factor XIIIa. However, the use 
of protease inhibitors directed at thrombin makes an activa- 
tion of factor XIII unlikely. The antibodies used in immuno- 
localization of  tissue transglutaminase in the rat growth plate 
do not cross-react with factor XIII (Aeschlimann and Pauls- 
son, 1991). Tissue transglutaminase, which does not require 
cleavage by thrombin for activation, must therefore be pres- 
ent.  The endogenous transglutaminase showed a  more re- 
stricted  substrate pattern  (Fig.  5  B) and only a  subset of 
those proteins detected by the exogenous enzyme (Fig. 5 C) 
were labeled. A predominantly labeled protein of apparent 
Mr "-30,000 was present in the growth plate but not in ar- 
ticular cartilage (Fig. 5 B; extract I, II; asterisk).  Collagen 
type II was not a major glutaminyl substrate for the endoge- 
nous enzyme under the conditions used (Fig.  5 B; extract 
III). Possibly, the affinity of the enzyme for collagen type II 
might be low compared to other substrate proteins, and the 
level of endogenous enzyme in the growth plate insufficient 
to give saturation labeling. There might also be differences 
in  the  substrate  specificity of the  endogenous enzyme in 
growth plate cartilage and of liver tissue transglutaminase, 
The Journal of Cell Biology, Volume  120,  1993  1466 Figure 5. Transglutaminase activity and protein substrates present in homogenates of growth plate cartilage (e) and articular cartilage (a). 
Homogenates derived from either growth plate (A-C) or articular cartilage (D) were incubated with monodansylcadaverine either in the 
absence (A, B) or presence (C, D) of purified tissue transglutaminase, sequentially extracted with buffered salt (I), guanidine/EDTA (II), 
and finally digested with pepsin (III), and subsequently analyzed by SDS-PAGE  on 4-20% gradient gels under reducing conditions. The 
gels were stained either with Coomassie brilliant blue R (A) or after electrophoretic transfer to nitrocellulose by incubation with antidansyl 
antiserum (B-D). Mr standards as well as the top and bottom of the separating gel (arrows) are indicated on the left. Bands assigned to 
collagen type II (Col I/) and tissue transglutaminase (tIG-') are indicated on the right. The prominent glutaminyl substrate protein of the 
endogenous transglutaminase (Mr ~  30,000) is marked with an asterisk (B). 
even  though  the  enzymes  share  epitopes  and  antibodies 
cross-react strongly. 
Tissue Transglutaminase Expression in Cartilages 
that Do Not Undergo Bone Formation and in Bones 
Formed by Intramembraneous Ossification 
Unfixed cryo-sections of  4-d old or adult rat trachea were as- 
sayed for tissue transglutaminase antigen or enzyme activity. 
The staining patterns were compared to the ones obtained 
with antibodies against osteonectin. In 4-d old rats, neither 
tissue transglutaminase nor osteonectin is expressed in the 
tracheal  cartilage  rings.  (Negative  controls  for  immuno- 
histochemical results are not shown but were submitted to 
the journal and available to the referees.) This is in agree- 
ment with the observation that resting chondrocytes in long 
bones  do  not  express  osteonectin  nor  tissue  transgluta- 
minase.  Surprisingly, in adult tracheal cartilage substantial 
amounts of osteonectin were found in the center of the rings 
(Fig.  6 A).  This could be correlated to calcification of the 
cartilage as seen with von Kossa's  stain for calcium phos- 
phate (Fig. 6  C).  Mineralization starts in the center of the 
tracheal rings and proceeds outwards with increasing age of 
the animal.  Moreover, tissue  transglutaminase  expression 
was also observed in adult trachea, either as intense spots 
corresponding to single cells or as a  faint staining  of the 
calcified cartilage matrix (Fig. 6 B). Careful comparison of 
the staining patterns for tissue transglutaminase and calcium 
phosphate deposits revealed that cells expressing the enzyme 
in large quantities are located at the calcification border (Fig. 
6, B  and  C).  These cells probably follow a differentiation 
program similar to that of growth plate chondrocytes, with 
the exception that no subsequent osteogenesis takes place. 
Similar results were obtained by staining tracheal sections 
for enzyme activity. Only adult rats were positive. Endoge- 
nous activity was present in the central, but not in the periph- 
eral region of the tracheal rings.  The activity was cell as- 
sociated in regions not yet calcified and extracellular in the 
calcified regions of the cartilage (results not shown). 
Similar to cortical bone and the bone matrix of trabeculae, 
the calvaria showed no expression of tissue transglutaminase 
protein (results not shown). In contrast, endogenous enzyme 
activity was present at high levels in newly deposited osteoid 
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calcified tracheal cartilage. Unfixed cryosections (5/zm) of adult rat 
trachea were stained with antibodies directed to osteonectin (A) or 
tissue transglutaminase (B) (negative controls for immunochemical 
results are not shown but were submitted to the journal  and avail- 
able to the referees), or were stained for hydroxyapatite with von 
(results  not  shown),  in  agreement with the  distribution  in 
long bone trabeculae (Fig. 4 A). This further supports the hy- 
pothesis that osteoblasts express a  different member of the 
transglutaminase  family. 
Discussion 
In the present study we investigated the expression of tissue 
transglutaminase in skeletal tissues. We found a correlation 
between  the  expression  of  the  enzyme  and  the  terminal 
differentiation of chondrocytes, both in endochondral bone 
formation and in the calcification of tracheal cartilage occur- 
ring with maturation. 
In long bones,  tissue  transglutaminase  expression is  in- 
duced  in  chondrocytes  in  the  proliferation  or  maturation 
zone  and  the  protein  is  subsequently  accumulated  in  the 
cytoplasm of the  cells during  further differentiation steps. 
Thus, tissue transglutaminase protein is highly enriched in 
hypertrophic chondrocytes, and is subsequently released in 
the zone of provisional calcification.  Externalization of the 
enzyme might possibly be due to physiologically occurring 
cell death or occur by an alternative way of secretion.  Con- 
ventional secretion is unlikely as tissue transglutaminase, as 
well as  factor XIII, does not have a  signal peptide,  is not 
glycosylated and does not contain disulfide bonds (Ichinose 
et al.,  1990).  One possible mechanism would be release of 
membrane-bound vesicles with cytoplasm-derived contents. 
So called matrix vesicles have been described in cartilage 
and other tissues and have been implicated in calcification 
(Wu et al.,  1991).  It is likely that the enzyme becomes acti- 
vated at the  elevated extracellular Ca  2+ concentrations  en- 
countered  upon  externalization.  Specific  glutaminyl  sub- 
strates for tissue transglutaminase like fibronectin (F6sus et 
al.,  1986), osteopontin (Prince et al.,  1991) and the N-pro- 
peptide of collagen type III (Bowness et al.,  1987)  are pres- 
ent in the cartilage and/or bone matrix (Heineg~rd and Old- 
berg,  1989;  Keene et al.,  1991).  Native osteonectin/BM40 
and collagen type II, which are present in the matrix of the 
growth plate, are additional glutaminyl substrates for tissue 
transglutaminase,  at  least  under  in  vitro  conditions.  The 
presence of specific substrates in the matrix of the growth 
plate, the observed redistribution of tissue transglutaminase 
from  an  intracellular  pool to  the  cartilage  matrix  during 
calcification,  and  the  demonstration  that  the  externalized 
enzyme is active, indicates a role for the enzyme in cross- 
linking of the matrix during terminal differentiation of chon- 
drocytes. The process of accumulation and consecutive acti- 
vation  of  tissue  transglutaminase  during  differentiation 
of chondrocytes resembles the well-characterized events oc- 
curring in ageing of erythrocytes and terminal differentiation 
of epidermal keratinocytes.  In leaking erythrocytes, tissue 
transglutaminase cross-links integral plasma membrane pro- 
teins and cytoskeletal proteins underlying the plasma mem- 
brane to  a  rigid coat  (Lorand and  Conrad,  1984),  and  in 
epidermis  the  keratinocyte transglutaminase  cross-links  a 
subset of cytoplasmic proteins, e.g., involucrin and loricrin, 
to form the cornified envelope of the epidermis (Thacher and 
Kossa's stain for calcium phosphate (C).  In B and C is the same 
field on serial sections shown, with arrowheads marking identical 
positions.  Bar, 50 ~m. 
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function of this sealing process might differ between tissues 
and physiological situations. It might play a role in prevent- 
ing leakage of substances influencing cell growth, prolifera- 
tion and differentiation.  The sealing might also function in 
maintaining the mechanical stability of the tissue and in scar 
formation. 
In tracheal cartilage, a tissue that does not undergo proper 
osteogenesis,  we  observed  that  calcification  occurs  with 
maturation,  as previously described by other investigators 
(Bonucci et al.,  1974).  Calcification  starts in the center of 
the rings and proceeds towards the periphery. It was accom- 
panied by prominent expression of osteonectin as well as ex- 
pression of tissue transglutaminase, analogous to the pattern 
observed in the growth plate. Tissue transglutaminase anti- 
gen and activity was observed most prominently in the carti- 
lage surrounding the hydroxyapatite deposits,  which shows 
some similarity to the hypertrophic cartilage of growth plate. 
Thus,  tissue  transglutaminase  and  osteonectin  expression 
are intimately associated with hypertrophy of chondrocytes 
and calcification of cartilage tissue, but not necessarily with 
bone formation.  There might be a second,  immunochemi- 
cally distinct transglutaminase acting in bone, as indicated 
by the fact that in newly deposited osteoid in long bones and 
in calvaria enzyme activity  was observed but tissue trans- 
glutaminase protein could not be detected. 
We observed osteonectin in hypertrophic chondrocytes of 
growth plate cartilage, in osteoblasts, in newly deposited os- 
teoid and mineralized  bone matrix of long bones and cal- 
varia. This agrees with the high level of expression of the os- 
teonectin gene found in growth plate cartilage, in bone tissue 
of long bones and calvaria,  and in the perichondrium and 
periosteum (Nomura et al.,  1988; Metsiiranta et al.,  1989). 
In situ hybridization of developing long bones revealed that 
osteoblasts  and hypertrophic  chondrocytes  contain  a  high 
level  of mRNA  whereas  resting  chondrocytes  do  not.  In 
agreement,  we did not observe any staining with the anti- 
osteonectin antiserum in the resting cartilage of developing 
long bones. Osteonectin has been proposed to have affinity 
for collagen and hydroxyapatite, and a potential role in the 
mineralization  process  was  suggested  (Termine  et  al., 
1981b). As the major cartilage collagen as well as osteonec- 
tin and fibronectin (F6sus et al., 1986) are specific substrates 
for tissue transglutaminase, it is likely that these proteins are 
cross-linked  upon  release  and  activation  of tissue  trans- 
glutaminase  in  growth  plate.  It  is  quite  possible  that the 
cross-linking of the organic matrix influences the structure 
and mechanical properties of the bone formed. 
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